Antimicrobial Emulsifier–Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low‐Grade Inflammation in Low‐Fat Diet Fed Mice
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Scope: Glycerol monolaurate (GML) is widely consumed worldwide in the food industry and is considered safe, but for chronic diseases, supporting scientific data remain sparse. This study investigates whether dietary GML induces metabolic syndrome, gut microbiota dysbiosis, and systemic low‐grade inflammation. Methods and results: GML‐induced occurrence of metabolic syndrome, gut microbiota alterations, and systemic low‐grade inflammation are investigated. The results demonstrate that GML induced metabolic syndrome by significantly increasing the body weight, weight gain, food intake, body fat, fat droplet size and percentage of epididymal fat, serum triglycerides (TG), LDL, and atherogenic index, and decreasing the body muscle ratio, liver weight, and HDL, compared to the control (CON) group. Meanwhile, GML significantly changed the β‐diversity and composition of gut microbiota and upregulated the circulating levels of serum LPS, IL‐1β, IL‐6, and TNF‐α. Importantly, GML significantly decreased Akkermansia muciniphila and Lupinus luteus, and increased Bacteroides acidifaciens, Escherichia coli and the microbial DNA abundance of the ten predicated metabolism pathways involved in carbohydrate, amino acid, and lipid metabolism. Conclusion: Our results indicate that relatively low‐dose GML consumption promotes metabolic syndrome, gut microbiota dysbiosis, and systemic low‐grade inflammation, thereby calling for a reassessment of GML usage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 1×
“The five screening components used to identify those with metabolic syndrome are fasting plasma glucose, abdominal obesity, circulating levels of triacylglycerols, high-density lipoprotein (HDL)-cholesterol and blood pressure [3].”
MethodThe impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710 · cited 2×
“Much progress has been made in the identification of LPS-suppressing genera and LPS-producing genera, revealing that LPS-producing families/genera are presented in several families/genera (Enterobacteriaceae, Clostridium cluster XI, Prevotella and SFB), and Lactobacillus, Bifidobacterium, Enterococcus faecium, Clostri…”
BackgroundNathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183 · cited 8×
“Serum LPS concentration (a), IL-1β (b), IL-6 (c), TNF-α (d) and IL-10 (e) (n = 6/group).”
BackgroundInfluentialLouis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067 · cited 1×
“As already demonstrated in previous studies [11, 23], dietary supplementation with non-caloric artificial sweetener (saccharin) and emulsifiers (CMC and P80), significantly promoted the metabolic syndrome by altering the diversity, composition and function of gut microbiota in mice.”
ResultDietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., & Gewirtz, A. T. (2015) · Nature · doi:10.1038/nature14232 · Cited by 2,055 · cited 5×
“Recent studies have demonstrated that gut microboita dysbiosis is a critical factor in the development of obesity and metabolic syndrome, possibly due to the increased energy harvest, production of toxic bacterial metabolites and greater intestinal permeability leading to elevated levels of LPS in systemic circulation…”
BackgroundResultInfluentialDao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., Kayser, B. D., Levenez, F., Chilloux, J., Hoyles, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308778 · Cited by 1,931 · cited 1×
“Specific and significant increase of Akkermansia muciniphila (widely considered as mucos-protection bacterium) [34-36] in the gut was important for reducing the host”
BackgroundAntibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613 · cited 1×
“2 GML induces gut microbiota dysbiosis As previous studies revealed the importance of gut microbiota and the close relationship between the metabolic syndrome and gut microbiota dysbiosis [21, 22], we further examined the alteration of the diversity and composition on gut microbiota between the GML and CON groups.”
BackgroundDuncan, S. H., Belenguer, A., Holtrop, G., Johnstone, A. M., Flint, H. J., & Lobley, G. E. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02340-06 · Cited by 941 · cited 1×
“Much progress has been made in the identification of LPS-suppressing genera and LPS-producing genera, revealing that LPS-producing families/genera are presented in several families/genera (Enterobacteriaceae, Clostridium cluster XI, Prevotella and SFB), and Lactobacillus, Bifidobacterium, Enterococcus faecium, Clostri…”
BackgroundIgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis
Peterson, D. A., McNulty, N. P., Guruge, J. L., & Gordon, J. I. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.013 · Cited by 828
Cited by
The Western Diet–Microbiome-Host Interaction and Its Role in Metabolic Disease
Zinöcker, M. K., & Lindseth, I. A. (2018) · doi:10.20944/preprints201803.0064.v1 · Cited by 776
Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health
Berding, K., Vlckova, K., Marx, W., Schellekens, H., Stanton, C., Clarke, G., Jacka, F., Dinan, T. G., & Cryan, J. F. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa181 · Cited by 451
Safety assessment of titanium dioxide (E171) as a food additive
(FAF), E. P. O. F. A. A. F., Younes, M., Aquilina, G., Castle, L., Engel, K., Fowler, P., Frutos Fernandez, M. J., Fürst, P., Gundert‐Remy, U., Gürtler, R., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6585 · Cited by 314
Ultra-processed foods and food additives in gut health and disease
Whelan, K., Bancil, A. S., Lindsay, J. O., & Chassaing, B. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00893-5 · Cited by 292
Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., & Jin, F. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00033 · Cited by 263
Metadata
- Authors
- Jiang, Z., Zhao, M., Zhang, H., Li, Y., Liu, M., & Feng, F.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2018-01-09
- Volume
- 62
- Issue
- 3
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2767571095
- Cited by
- 125
- References
- 19
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial Emulsifier–Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low‐Grade Inflammation in Low‐Fat Diet Fed Mice. https://app.cochat.ai/papers/10.1002/mnfr.201700547
- The paper
- Jiang, Z., Zhao, M., Zhang, H., Li, Y., Liu, M., & Feng, F. (2018). Antimicrobial Emulsifier–Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low‐Grade Inflammation in Low‐Fat Diet Fed Mice. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.201700547
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.